Obesity and “functional hypogonadism”—mechanisms and management: commentary on EJE-22-1110 “leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind RCT”-Reference-Cited by-同舟云学术

Obesity and “functional hypogonadism”—mechanisms and management: commentary on EJE-22-1110 “leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind RCT”

Published:2023-08-07 Issue:3 Volume:189 Page:R7-R9
ISSN:0804-4643
Container-title:European Journal of Endocrinology
language:en
Short-container-title:

Author:

Inder Warrick J¹²^ORCID,Grossmann Mathis³⁴^ORCID

Affiliation:

1. Department of Diabetes and Endocrinology, Princess Alexandra Hospital , 199 Ipswich Rd, Woolloongabba, QLD 4102 , Australia

2. PA-Southside Clinical Unit Medical School, The University of Queensland , 199 Ipswich Rd, Woolloongabba, QLD 4102 , Australia

3. Department of Medicine, Austin Health University of Melbourne , 145 Studley Road, Heidelberg, VIC 3084 , Australia

4. Department of Endocrinology, Austin Health , 145 Studley Road, Heidelberg, VIC 3084 , Australia

Publisher

Oxford University Press (OUP)

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Link

https://academic.oup.com/ejendo/advance-article-pdf/doi/10.1093/ejendo/lvad100/51046142/lvad100.pdf

Reference12 articles.

1. Hypogonadism and male obesity: focus on unresolved questions;Grossmann;Clin Endocrinol (Oxf),2018

2. Approach to the patient: the evaluation and management of men ≥50 years with a low serum testosterone concentration;Grossmann;J Clin Endocrinol Metab

3. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis;Corona;Eur J Endocrinol,2013

4. Low estradiol concentrations in men with subnormal testosterone concentrations and type 2 diabetes;Dhindsa;Diabetes Care,2011

5. Mechanisms in endocrinology: estradiol as a male hormone;Russell;Eur J Endocrinol,2019